Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Investigational New Drugs|April 14, 2021
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumorsGerald S Falchook, Marc Peeters, Sylvie Rottey, et al.The AAPS Journal|October 14, 2025
Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin MoleculesNichole A Reynolds, Yan Q Chen, Richard E Higgs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2021
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 AntibodyJames J Harding, Victor Moreno, Yung-Jue Bang, et al.Nature|October 14, 2008
DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytesAndrea L Bredemeyer, Beth A Helmink, Cynthia L Innes, et al.Immunity|January 21, 2014
Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammationSlava Epelman, Kory J Lavine, Anna E Beaudin, et al.Bioanalysis|February 23, 2024
2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard <u>(Part 3</u> - Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Biotherapeutics Immunogenicity & Risk Assessment; ADA/NAb Assay/Reporting Harmonization)Johanna Mora, Rachel Palmer, Leslie Wagner, et al.Pageof 4